Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans.

about

Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans.

Item

http://www.wikidata.org/entity/Q39798811

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment with rilpivirine doe ...... lafil and midazolam in humans.

@en

Treatment with rilpivirine doe ...... lafil and midazolam in humans.

@nl

type

Item

label

Treatment with rilpivirine doe ...... lafil and midazolam in humans.

@en

Treatment with rilpivirine doe ...... lafil and midazolam in humans.

@nl

prefLabel

Treatment with rilpivirine doe ...... lafil and midazolam in humans.

@en

Treatment with rilpivirine doe ...... lafil and midazolam in humans.

@nl

P1476

Treatment with rilpivirine doe ...... alafil and midazolam in humans

@en

P2093

Alexandra Carls

http://www.w3.org/2001/XMLSchema#string

Jürgen Burhenne

http://www.w3.org/2001/XMLSchema#string

Lukas Witt

http://www.w3.org/2001/XMLSchema#string

Raphael Reinhard

http://www.w3.org/2001/XMLSchema#string

Sven Schnaidt

http://www.w3.org/2001/XMLSchema#string

P2860

Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection

Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?

Rilpivirine.

Influence of HIV antiretrovirals on methadone N-demethylation and transport.

Agonism of human pregnane X receptor by rilpivirine and etravirine: comparison with first generation non-nucleoside reverse transcriptase inhibitors.

Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro.

Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.

The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers.

Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers.

Prevalence and factors associated with erectile dysfunction in a cohort of HIV-infected patients.

P304

2241-2247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKW125

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerd Mikus

Walter E Haefeli

Nicolas Hohmann

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27141088

http://www.w3.org/2001/XMLSchema#string